New device aims to prevent blocked arteries during repeat heart valve surgery
NCT ID NCT06211296
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device called ShortCut that splits the leaflets of a failing artificial heart valve before placing a new valve inside it. The goal was to prevent the old leaflets from blocking the coronary arteries, which can cause a heart attack. Eight people at risk for this complication took part, and researchers measured how well the device split the leaflets and whether it caused death or stroke.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ShortCut device (splits bioprosthetic aortic valve leaflets)
What this could lead to
If successful, this device could help prevent serious complications like heart attack or stroke during valve-in-valve procedures for people with failing artificial heart valves.
What could go wrong
This was a very small study (8 people) with no comparison group, so results may not apply widely. The device itself carries risks of death or stroke.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center /NYPH
New York, New York, 10032, United States
-
Los Robles Regional Medical Center
Thousand Oaks, California, 91360, United States
-
Morristown Medical Center
Morristown, New Jersey, 07960, United States
-
UPMC Pinnacle
Wormleysburg, Pennsylvania, 17043, United States